US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT07759128 Phase 3
Recruiting
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...
Condition
Generalized Anxiety Disorder
Enrollment
576 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Developm
View Trial →
NCT07440225 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Argentina, Australia
Sponsor
EyeBiotech Ltd.
View Trial →
NCT06859762 Phase 1
Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
630 pts
Location
United States, China
Sponsor
MediLink Therapeutics (Suzhou)
View Trial →
NCT06280950 Phase 2
Recruiting
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Condition
Liver Transplant
Enrollment
340 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT04953559 N/A
Recruiting
Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
Condition
Insomnia, Primary
Enrollment
20 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT07682896 Phase 2
Recruiting
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in...
Condition
Graves' Disease
Enrollment
232 pts
Location
United States, Australia
Sponsor
Yarrow Bioscience, Inc.
View Trial →
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06834373 Phase 2
Recruiting
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggress...
Condition
Large B-Cell Lymphoma With IRF4 Rearrangement
Enrollment
41 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07559903 N/A
Recruiting
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Eff...
Condition
Coronary Artery Disease
Enrollment
5,000 pts
Location
United States, Germany, Serbia
Sponsor
Emory University
View Trial →
NCT05319730 Phase 1, Phase 2
Recruiting
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-347...
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
230 pts
Location
United States, Brazil, Chile
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05645107 Phase 3
Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatm...
Condition
Hypogammaglobulinemia
Enrollment
386 pts
Location
United States, Bosnia and Herzegovina, Bulgaria
Sponsor
Grifols Therapeutics LLC
View Trial →
NCT07594106 Phase 1, Phase 2
Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMA...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
265 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06743126 Phase 3
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously T...
Condition
Melanoma, Cutaneous Malignant
Enrollment
450 pts
Location
United States, Canada, France
Sponsor
Immatics US, Inc.
View Trial →
NCT07775300 Phase 3
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive D...
Condition
Depressive Disorder, Major
Enrollment
1,000 pts
Location
United States, Australia, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT06555419 Phase 1
Recruiting
A Study to Find Out How Nusinersen is Processed in the Body When Given Through t...
Condition
Muscular Atrophy, Spinal
Enrollment
78 pts
Location
United States, France, Germany
Sponsor
Biogen
View Trial →
NCT07223593 Phase 3
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disea...
Condition
Peripheral Arterial Disease
Enrollment
1,205 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT06851338 N/A
Recruiting
Pediatric Down Syndrome Post-Approval Study
Condition
Pediatric Obstructive Sleep Apnea
Enrollment
60 pts
Location
United States
Sponsor
Inspire Medical Systems, Inc.
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06327685 Phase 1
Recruiting
Avapritinib With Decitabine in Patients With SM-AHN
Condition
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Enrollment
34 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT06265103 N/A
Recruiting
Epilepsy Learning Healthcare System (ELHS)
Condition
Epilepsy
Enrollment
100,000 pts
Location
United States
Sponsor
Epilepsy Foundation of America
View Trial →
NCT06556654 N/A
Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (RE...
Condition
Breast Reconstruction Surgery
Enrollment
180 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT07409103 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat ...
Condition
Active Rheumatoid Arthritis
Enrollment
180 pts
Location
United States, Serbia, South Africa
Sponsor
Elevara Medicines Limited
View Trial →
NCT06850623 Phase 2
Recruiting
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Ad...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
25 pts
Location
United States, United Kingdom
Sponsor
EXACT Therapeutics AS
View Trial →
NCT06707090 Phase 3
Recruiting
Tissue Repair Gel in Venous Leg Ulcers (US)
Condition
Venous Leg Ulcer
Enrollment
312 pts
Location
United States
Sponsor
TR Therapeutics
View Trial →
Page 8 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology